Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
Titel:
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China
Auteur:
Li, Jian Zhang, Jun Zhang, Yanqiao Qiu, Haibo Zhou, Yanbing Zhou, Yongjian Zhang, Xinhua Zhou, Ye Zhu, Yuping Li, Yong Wang, Ming Shen, Kuntang Tao, Kaixiong Wu, Xin Wang, Haijiang Zhang, Bo Ling, Jiayu Ye, Yingjiang Wu, Xingye Qu, Hongyan Ma, Yue Jiao, Xuelong Zheng, Hualong Jin, Jiejie Liu, Zhuo Tan, Ming Fang, Yong Zhang, Peng Zhang, Nan Lei, Cheng Cai, Zhaolun Liang, Bin Peng, Zhangyan Huang, Zhao Dong, Juan Shen, Lin